Skip to main content

Madeira for malaria?

Of all of the scourges of mankind, malaria ranks near the top of the list, affecting more people worldwide that the entire population of the U.S. It has been notoriously resistant to vaccines, in part because of the complex life cycle of the parasite, which spends part of its development in the mosquito and part inside the red blood cells of people. It is this latter part that raises an interesting possibility for treatment with the red wine compound resveratrol, as reported at a recent meeting of tropical medicine specialists.


You may be familiar with the antibiotic properties of resveratrol and other polyphenol molecules from red wine. These compounds come from the skins, where the grapes form them as part of their natural environmental defense. Plants, and especially ripening fruit, are vulnerable to bacteria, viruses and fungus just as animal are, and this explains the broad spectrum of antibiotic capabilities of resveratrol. Wine’s use as a means of purifying drinking water over the past few thousand years is likely based as much on this as its alcohol content. Parasites such as the malaria bug are more difficult to suppress, and so the activity of resveratrol was unexpected.

One reason for this is that resveratrol’s inhibition of malaria works indirectly, by altering the red blood cells that contain the bug. In order for the more sever manifestations of malaria to occur, the blood cells need to adhere to the lining of the blood vessels, which resveratrol prevents (this is actually related to how it helps prevent heart attacks). So the idea isn’t that resveratrol can eradicate the parasite, but rather to mitigate the more severe effects of it while treating with anti-malarial drugs.

Since malaria is most common in tropical climates and developing countries, any effect of wine consumption would be a difficult association to discover. The British, during the Raj turned to quinine and the now-classic gin & tonic rather than claret for the same practical reasons. It is a bit difficult to picture fine Bordeaux becoming the standard prophylaxis in sub-Saharan Africa, but it may well hold the key to minimizing a lot of suffering.

Comments

Popular posts from this blog

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...

Should wine labels make health claims?

Winemakers have been in a debate for some years now with the U.S. Department of Treasury's Alcohol, Tax and Trade Bureau (formerly the ATF, for Alcohol, Tobacco, and Firearms--yeah, that made a lot of sense) about ingredient listing for wines, particularly since the healthful properties of wine polyphenols such as resveratrol have been widely publicised. A couple of years back, an Oregon pinot noir producer gained approval for a fairly benign claim: "Pinot noir develops a natural defense against botrytis (mold) in our moist, cool climate - the antioxidant resveratrol." Since resveratrol is indeed produced in the skins of grapes subjected to certain environmental stresses such as mold, and Oregon's climate is certifiably moist, it seems a fairly harmless claim. However, the feds simultaneously disallowed placing the same wording on another vintage from the same producer, citing concern about making therapeutic claims on labels or creating "misleading" associa...